Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone B cells - % of B2 cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone B cells - % of B2 cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total T cells - % of CD45+
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total T cells - % of CD45+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC contacting LC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC contacting LC
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC contacting LC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC contacting LC
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Granulocytes - % of myeloid cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Granulocytes - % of myeloid cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-pro B cells (Hardy fraction A) - % of B220+
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-pro B cells (Hardy fraction A) - % of B220+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ NK cells - % of NK cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ NK cells - % of NK cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Naive CD8+ T cells - % of CD8+
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Naive CD8+ T cells - % of CD8+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0138
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean cell hemoglobin concentration
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.134
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.344
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Mean cell hemoglobin concentration
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.550
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.556
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Mean cell hemoglobin concentration
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.968
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD4+ T helper cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD4- NKT cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total myeloid cells - % of CD45+
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total myeloid cells - % of CD45+
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B cells - % of CD45+
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B cells - % of CD45+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Mean platelet volume
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.221
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Mean platelet volume
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.346
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean platelet volume
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.468
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Mean platelet volume
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.571
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean platelet volume
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.605
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Mean platelet volume
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.992
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Eosinophil differential count
|
HOM
|
8f:m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.230
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Eosinophil differential count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.682
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Naive CD8+ T cells - % of CD8+
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Naive CD8+ T cells - % of CD8+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector gd T cells - % of gd T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector gd T cells - % of gd T cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting gd T cells - % of gd T cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting gd T cells - % of gd T cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasmacytoid DC - % of DC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasmacytoid DC - % of DC
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Cytotoxic T cell function / % lysis
|
HOM
|
6f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Cytotoxic T cell function / % lysis
|
HEM
|
f:12m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Organ Weight / Spleen weight
|
HEM
|
f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.592
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4- NKT cells - % of NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4- NKT cells - % of NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / Monocyte percentage
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / Monocyte percentage
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ mature NK cells - % of mature NK cells
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ mature NK cells - % of mature NK cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD4+ T helper cells - % of CD4+
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD4+ T helper cells - % of CD4+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Vg5+ dendritic epidermal T cell (DETC) count
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Vg5+ dendritic epidermal T cell (DETC) count
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasma cells - % of B2 cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasma cells - % of B2 cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Follicular B cells - % of B2 cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Follicular B cells - % of B2 cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / CD8+CD44+CD62L- percentage
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / CD8+CD44+CD62L- percentage
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ Treg cells - % of Treg
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ Treg cells - % of Treg
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Granulocytes - % of myeloid cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Granulocytes - % of myeloid cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD4+ T helper cells - % of CD4+
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD4+ T helper cells - % of CD4+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC not contacting LC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC not contacting LC
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Hematocrit
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.213
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Hematocrit
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.368
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Hematocrit
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.587
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Hematocrit
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.754
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Hematocrit
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.802
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Hematocrit
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.895
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Memory B cells - % of B2 cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Memory B cells - % of B2 cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC not contacting LC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC not contacting LC
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD103+ CD11b-low cDC - % of CD11b-low cDC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD103+ CD11b-low cDC - % of CD11b-low cDC
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction C) - % of B220+
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction C) - % of B220+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4- NKT cells - % of NKT cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4- NKT cells - % of NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Myeloid cells - % of CD45+
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Myeloid cells - % of CD45+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD4+ T helper cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Germinal centre B cells - % of B2 cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Germinal centre B cells - % of B2 cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ Treg cells - % of Treg
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ Treg cells - % of Treg
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone precursor B cells - % of B2 cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone precursor B cells - % of B2 cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD4- NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasmacytoid DC - % of DC
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasmacytoid DC - % of DC
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Lymphocyte cell count
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.264
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Lymphocyte cell count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.712
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector NK cells - % of NK cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector NK cells - % of NK cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / T cell CD8+ percentage
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / T cell CD8+ percentage
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD103+ CD11b-low cDC - % of CD11b-low cDC
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD103+ CD11b-low cDC - % of CD11b-low cDC
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total Treg cells - % of CD4+
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total Treg cells - % of CD4+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Platelet count
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00581
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Platelet count
|
HEM
|
f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.164
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Platelet count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.292
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Platelet count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.881
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Platelet count
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.947
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Platelet count
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.969
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / NK cell percentage
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / NK cell percentage
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4- NKT cells - % of CD4- NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC not contacting LC
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC not contacting LC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Late germinal centre B cells - % of GC cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Late germinal centre B cells - % of GC cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Follicular B cells - % of B2 cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Follicular B cells - % of B2 cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone precursor B cells - % of B2 cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone precursor B cells - % of B2 cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ NKT cells - % of NKT cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ NKT cells - % of NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ CD5+ T cells - % of CD5+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ CD5+ T cells - % of CD5+ T cells
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC not contacting LC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC not contacting LC
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total DC - % of myeloid cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total DC - % of myeloid cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector gd T cells - % of gd T cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector gd T cells - % of gd T cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of LC
|
HEM
|
f:2m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of LC
|
HOM
|
2f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD8+ T cells - % of CD8+
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD8+ T cells - % of CD8+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / Granulocyte Gr1+ percentage
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / Granulocyte Gr1+ percentage
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Macrophages - % of myeloid cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Macrophages - % of myeloid cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B1a cells - % of B cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B1a cells - % of B cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting NK cells - % of NK cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting NK cells - % of NK cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Eosinophil cell count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.331
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Eosinophil cell count
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.952
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD5+ gd T cells - % of gd T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD5+ gd T cells - % of gd T cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Hemoglobin
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.308
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Hemoglobin
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.535
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Hemoglobin
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.612
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Hemoglobin
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.654
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Hemoglobin
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.945
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Hemoglobin
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.998
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ T cells - % of ab T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ T cells - % of ab T cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasma cells - % of B2 cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasma cells - % of B2 cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting gd T cells - % of gd T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting gd T cells - % of gd T cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC contacting LC
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC contacting LC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ T helper cells - % of CD4+ T helper cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-low cDC - % of cDC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-low cDC - % of cDC
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-B cells (Hardy fraction D) - % of B220+
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-B cells (Hardy fraction D) - % of B220+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / T cell CD3+ percentage
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / T cell CD3+ percentage
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B cells - % of CD45+
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B cells - % of CD45+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ NKT cells - % of NKT cells
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ NKT cells - % of NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ NKT cells - % of CD4+ NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Neutrophil differential count
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.0197
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Neutrophil differential count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.826
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Eosinophils - % of myeloid cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Eosinophils - % of myeloid cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD8+ T cells - % of ab T cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD8+ T cells - % of ab T cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Granulocytes - % of CD45+
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Granulocytes - % of CD45+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ NKT cells - % of CD4+ NKT cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NK cells - % of CD45+
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NK cells - % of CD45+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Lymphocyte differential count
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0493
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Lymphocyte differential count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.888
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total DC - % of myeloid cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total DC - % of myeloid cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Mature NK cells - % of NK cellls
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Mature NK cells - % of NK cellls
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD8+ T cells - % of CD8+
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD8+ T cells - % of CD8+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 2 B cells - % of B2 cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 2 B cells - % of B2 cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting NK cells - % of NK cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting NK cells - % of NK cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Monocyte differential count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.932
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Monocyte differential count
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.990
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / NKT cell percentage
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / NKT cell percentage
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total gd T cells - % of total T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total gd T cells - % of total T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Plasma cells - % of CD45+
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Plasma cells - % of CD45+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting Treg cells - % of Treg
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting Treg cells - % of Treg
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4- NKT cells - % of CD4- NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 1 B cells - % of B2 cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 1 B cells - % of B2 cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ T helper cells - % of CD4+ T helper cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total ab T cells - % of total T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total ab T cells - % of total T cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of LC
|
HEM
|
f:2m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of LC
|
HOM
|
2f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector NK cells - % of NK cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector NK cells - % of NK cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting Treg cells - % of Treg
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting Treg cells - % of Treg
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total gd T cells - % of total T cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total gd T cells - % of total T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
DSS Histology / Pre-Day 10 Death
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
DSS Histology / Pre-Day 10 Death
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Mean cell volume
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Mean cell volume
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Mean cell volume
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Mean cell volume
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean cell volume
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.599
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean cell volume
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.620
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Germinal centre B cells - % of B2 cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Germinal centre B cells - % of B2 cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD8+ T cells - % of CD8+
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD8+ T cells - % of CD8+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ NKT cells - % of CD4+ NKT cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ T helper cells - % of CD4+ T helper cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Immature B cells (Hardy fraction E) - % of B220+
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Immature B cells (Hardy fraction E) - % of B220+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total myeloid cells - % of CD45+
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total myeloid cells - % of CD45+
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total ab T cells - % of total T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total ab T cells - % of total T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Basophil cell count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.223
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Basophil cell count
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.262
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-high cDC - % of cDC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-high cDC - % of cDC
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B2 cells - % of B cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B2 cells - % of B cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Red blood cell count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.301
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Red blood cell count
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.428
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Red blood cell count
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.464
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Red blood cell count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.711
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Red blood cell count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.716
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Red blood cell count
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.742
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / B cell CD19+ percentage
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / B cell CD19+ percentage
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NKT cells - % of CD45+
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NKT cells - % of CD45+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ gd T cells - % of gd T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ gd T cells - % of gd T cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / Mature B cell IgD+ percentage
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / Mature B cell IgD+ percentage
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-high cDC - % of cDC
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-high cDC - % of cDC
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Early germinal centre B cells - % of GC cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Early germinal centre B cells - % of GC cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD4+ NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / T cell CD4+ percentage
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / T cell CD4+ percentage
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B1a cells - % of B cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B1a cells - % of B cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Neutrophil cell count
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.397
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Neutrophil cell count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.546
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Eosinophils - % of myeloid cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Eosinophils - % of myeloid cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ immature NK cells - % of immature NK cells
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Ly6C+ immature NK cells - % of immature NK cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD8+ T cells - % of CD8+
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD8+ T cells - % of CD8+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ NKT cells - % of CD4+ NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector Treg cells - % of Treg
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector Treg cells - % of Treg
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Late germinal centre B cells - % of B2 cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Late germinal centre B cells - % of B2 cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fractions B and C) - % of B220+
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fractions B and C) - % of B220+
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Trichuris / Presence of worms in caecum
|
HOM
|
6f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Total B cells - % of CD45+
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Total B cells - % of CD45+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Monocytes - % of myeloid cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Monocytes - % of myeloid cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD8+ T cells - % of CD8+
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD8+ T cells - % of CD8+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD5+ gd T cells - % of gd T cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD5+ gd T cells - % of gd T cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Organ Weight / Thymus weight
|
HEM
|
f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0356
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
DSS Histology / Average histology score
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
DSS Histology / Average histology score
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Conventional DC (cDC) - % of DC
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Conventional DC (cDC) - % of DC
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Memory B cells - % of B2 cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Memory B cells - % of B2 cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4- NKT cells - % of CD4- NKT cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector Treg cells - % of Treg
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector Treg cells - % of Treg
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Anti-nuclear antibody assay / ANA classification
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Anti-nuclear antibody assay / ANA classification
|
HEM
|
f:3m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Trichuris / Pre day 32 death
|
HOM
|
6f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ NK cells - % of NK cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ NK cells - % of NK cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Monocyte cell count
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.406
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Monocyte cell count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.647
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Immature NK cells - % of NK cells
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Immature NK cells - % of NK cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / CD4+CD44+CD62L- percentage
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / CD4+CD44+CD62L- percentage
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NKT cells - % of CD45+
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NKT cells - % of CD45+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NK cells - % of CD45+
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NK cells - % of CD45+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ T cells - % of ab T cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ T cells - % of ab T cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0121
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Mean corpuscular hemoglobin
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.249
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean corpuscular hemoglobin
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.485
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.497
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.743
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Mean corpuscular hemoglobin
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.971
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 2 B cells - % of B2 cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 2 B cells - % of B2 cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of LC
|
HEM
|
f:2m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of LC
|
HOM
|
2f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ T helper cells - % of CD4+ T helper cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Conventional DC (cDC) - % of DC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Conventional DC (cDC) - % of DC
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Mature B cells (Hardy fraction F) - % of B220+
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Mature B cells (Hardy fraction F) - % of B220+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / T cells - % of CD45+
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / T cells - % of CD45+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 1 B cells - % of B2 cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 1 B cells - % of B2 cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ gd T cells - % of gd T cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ gd T cells - % of gd T cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC contacting LC
|
HOM
|
2f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC contacting LC
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Basophil differential count
|
HOM
|
8f:m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.292
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Basophil differential count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.492
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD4+ NKT cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD8+ T cells - % of CD8+
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD8+ T cells - % of CD8+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Macrophages - % of myeloid cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Macrophages - % of myeloid cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Monocytes - % of myeloid cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Monocytes - % of myeloid cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone B cells - % of B2 cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone B cells - % of B2 cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD8+ T cells - % of ab T cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD8+ T cells - % of ab T cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Red blood cell distribution width
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.00706
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Red blood cell distribution width
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.170
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / Red blood cell distribution width
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.417
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / Red blood cell distribution width
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.479
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Red blood cell distribution width
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.673
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / Red blood cell distribution width
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.965
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Langerhans cell (LC) count
|
HEM
|
f:2m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Langerhans cell (LC) count
|
HOM
|
2f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell percentage
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell percentage
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on LC
|
HOM
|
2f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on LC
|
HEM
|
f:2m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell number
|
HOM
|
7f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell number
|
HEM
|
f:7m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4- NKT cells - % of CD4- NKT cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-low cDC - % of cDC
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-low cDC - % of cDC
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction B) - % of B220+
|
HEM
|
f:1m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction B) - % of B220+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / Treg cell CD25+ percentage
|
HEM
|
f:7m
|
|
|
NotProcessed |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Buffy coat peripheral blood leukocyte immunophenotyping / Treg cell CD25+ percentage
|
HOM
|
7f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B2 cells - % of B cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B2 cells - % of B cells
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Early germinal centre B cells - % of B2 cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Early germinal centre B cells - % of B2 cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total T cells - % of CD45+
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total T cells - % of CD45+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total Treg cells - % of CD4+
|
HEM
|
f:2m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total Treg cells - % of CD4+
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / White blood cell count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.000920
|
Successful |
Rbmxtm2a(KOMP)Wtsi
|
WTSI
|
Hematology / White blood cell count
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.222
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / White blood cell count
|
HOM
|
7f:m
|
Linear Mixed Model framework, LME, including Weight
|
0.386
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / White blood cell count
|
HOM
|
8f:m
|
Linear Mixed Model framework, LME, not including Weight
|
0.433
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Hematology / White blood cell count
|
HEM
|
f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.563
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
UC Davis
|
Hematology / White blood cell count
|
HEM
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.611
|
Successful |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ NKT cells - % of NKT cells
|
HEM
|
f:3m
|
|
|
NotProcessed |
Rbmxtm2b(KOMP)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ NKT cells - % of NKT cells
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |